{"componentChunkName":"component---node-modules-gatsby-theme-buzzing-src-gatsby-theme-blog-core-templates-post-query-js","path":"/tweet/1429962955916038148","result":{"data":{"site":{"siteMetadata":{"title":"国外股市热门","author":"Buzzing.cc","description":"用中文浏览国外股票社区里的热门讨论","keywords":["buzzing","美股","股票","股市"],"siteUrl":"https://stocks.buzzing.cc","telegram":"@stocks_top","iconUrl":"https://stocks.buzzing.cc/avatar.png","defaultSocialImageUrl":null,"social":[{"name":"Reddit Stocks","url":"https://www.reddit.com/r/stocks","external":true},{"name":"Reddit Investing","url":"https://www.reddit.com/r/investing","external":true},{"name":"Charlie Bilello's twitter","url":"https://twitter.com/charliebilello","external":true},{"name":"Buzzing","url":"https://www.buzzing.cc/","external":true}],"menuLinks":[{"name":"每周精选","url":"/issues","external":null}],"disqus":null,"utterances":null,"localize":[{"title":"Buzzing on Stocks","description":"See popular discussions in foreign stock communities in your native language","keywords":["buzzing","stocks","U.S. stocks"],"locale":"en","social":{"name":null,"url":null,"external":null},"menuLinks":[{"name":"Weekly Selection","url":"/en/issues","external":null}]},{"title":"國外股市熱門","description":"用中文瀏覽國外股票社區裡的熱門討論","keywords":["buzzing","美股","股票","股市"],"locale":"zh-Hant","social":null,"menuLinks":[{"name":"每週精選","url":"/zh-Hant/issues","external":null}]},{"title":"米国株式市場人気の話し合います","description":"人気の米国株式市場の話し合いまを日本語で閲覧","keywords":["buzzing","米国株式市場"],"locale":"ja","social":null,"menuLinks":[]}]}},"blogPost":{"id":"TweetPost-1429962955916038148","excerpt":"","body":"","slug":"/tweet/1429962955916038148","title":"RT @AndySwan: FDA APPROVAL requires Pfizer to submit study results analyzing risk of myocarditis and pericarditis, and risk to long-term in…","tags":["tweet"],"date":"August 24, 2021","dateISO":"2021-08-24T01:07:14.000Z","datetime":"2021-08-24 01:07","image":null,"imageAlt":null,"socialImage":null,"__typename":"SocialMediaPost","thirdPartyId":"1429962955916038148","provider":"Twitter","url":"https://twitter.com/The_Real_Fly/statuses/1429962955916038148","originalUrl":null,"imageRemote":null,"video":null,"channel":null,"channelUrl":null,"author":"The_Real_Fly","authorUrl":"https://twitter.com/The_Real_Fly","authorImage":null,"authorImageRemote":"https://pbs.twimg.com/profile_images/1365459205453471751/LL4GKo3m.jpg","authorSlug":"The_Real_Fly","score":11824,"views":null,"sharedCount":5912,"likeCount":0,"sharedContent":{"excerpt":"","slug":"","title":"FDA APPROVAL requires Pfizer to submit study results analyzing risk of myocarditis and pericarditis, and risk to long-term infant development in pregnant women.\n\nStudy results reports will be submitted to the FDA for review on Oct 31, 2025 and May 31, 2027 respectively.","date":"August 23, 2021","dateISO":"2021-08-23T15:36:03.000Z","datetime":"2021-08-23 15:36","tags":[],"imageRemote":null,"image":null,"imageAlt":null,"authorImageRemote":"https://pbs.twimg.com/profile_images/1400170494196920322/d_2WQXFb.jpg","authorImage":null,"video":null,"channel":null,"channelUrl":null,"author":"Swanstradomus","authorUrl":"https://twitter.com/statuses/AndySwan","authorSlug":"AndySwan","score":null,"views":null,"sharedCount":null,"likeCount":null},"parent":{"localize":[{"locale":"ja","full_text":"RT @AndySwan: FDAの承認には、心筋炎や心膜炎のリスク、長期的な入院生活へのリスクを分析した試験結果をファイザー社に提出することが求められています。","quoted_status_full_text":null,"retweeted_status_full_text":"FDAの承認を得るためには、心筋炎や心膜炎のリスク、および妊娠中の女性における長期的な乳児の発達に対するリスクを分析した試験結果をファイザー社が提出する必要があります。\n\n試験結果の報告は、2025年10月31日および2027年5月31日にそれぞれFDAに提出され、審査される予定です。"},{"locale":"zh","full_text":"RT @AndySwan: FDA批准要求辉瑞公司提交研究结果，分析心肌炎和心包炎的风险，以及对长期住院的风险。","quoted_status_full_text":null,"retweeted_status_full_text":"FDA的批准要求辉瑞公司提交研究结果，分析心肌炎和心包炎的风险，以及对孕妇长期婴儿发育的风险。\n\n研究结果报告将分别于2025年10月31日和2027年5月31日提交给FDA审查。"},{"locale":"zh-Hant","full_text":"RT @AndySwan: FDA批准要求輝瑞公司提交研究結果，分析心肌炎和心包炎的風險，以及對長期住院的風險。","quoted_status_full_text":null,"retweeted_status_full_text":"FDA的批准要求輝瑞公司提交研究結果，分析心肌炎和心包炎的風險，以及對孕婦長期嬰兒發育的風險。\n\n研究結果報告將分別於2025年10月31日和2027年5月31日提交給FDA審查。"}]}},"previous":{"id":"TweetPost-1429898657424347143","excerpt":"","slug":"/tweet/1429898657424347143","title":"There are only 25 EtherTopazRock. I own one of them.\n\nTres comas, here I come. https://t.co/6ekLwiHP2U","date":"August 24, 2021","__typename":"SocialMediaPost","provider":"Twitter","parent":{"localize":[{"locale":"ja","full_text":"EtherTopazRockは25個しかありません。私はそのうちの1つを所有しています。\n\nTres comas, here I come. https://t.co/6ekLwiHP2U","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh","full_text":"只有25个EtherTopazRock。我拥有其中之一。\n\nTres comas, here I come. https://t.co/6ekLwiHP2U","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh-Hant","full_text":"只有25個EtherTopazRock。我擁有其中之一。\n\nTres comas, here I come. https://t.co/6ekLwiHP2U","quoted_status_full_text":null,"retweeted_status_full_text":null}]}},"next":{"id":"RedditPost-87fa8a15-e0c9-5a0f-ae6d-0676dd8bb733","excerpt":"It seems like most of these stocks have their 52 week high some time in\nFebruary, outside of large tech companies. The speculative stocks, SPACs, small\ncaps, mid caps, meme stocks and growth stocks have all be in a downward spiral\nof over 45%+ since February. So what bubble are we in, when its only…","slug":"/reddit/r/stocks/comments/paabed/didnt_the_bubble_already_burst_back_in_february/","title":"Didn't the bubble already burst back in February?","__typename":"SocialMediaPost","date":"August 24, 2021","provider":"Reddit","parent":{"localize":[{"title":"2月にはすでにバブルが崩壊していたのでは？","the_new_excerpt":"これらの銘柄の多くは、52週目の高値を2月中につけているようです。\n大規模なハイテク企業を除いて、ほとんどの銘柄が2月のある時点で52週目の高値をつけているようです。投機的な銘柄、SPAC、小型株、中型株、ミーム株、成長株はすべて下降しています。\n投機株、SPAC、小型株、中型株、ミーム株、グロース株などは、2月以降、45％以上の下降スパイラルに陥っている。\n2月以降、45％以上も下落しています。では、どのようなバブルが発生しているのでしょうか。","locale":"ja"},{"title":"泡沫不是早在2月份就已经破裂了吗？","the_new_excerpt":"似乎这些股票中的大多数都在2月份的某个时候达到了52周的高点。\n2月，除了大型科技公司之外。投机性股票、SPACs、小盘股、中盘股、纪念性股票和成长性股票都在下跌。\n投机股、SPACs、小盘股、中盘股、记忆股和成长股自2月以来都处于下跌的漩涡中。\n自2月以来，超过45%以上。那么，我们处于什么泡沫中，当它只是...","locale":"zh"},{"title":"泡沫不是早在2月份就已經破裂了嗎？","the_new_excerpt":"似乎這些股票中的大多數都在2月份的某個時候達到了52周的高點。\n2月，除了大型科技公司之外。投機性股票、SPACs、小盤股、中盤股、紀念性股票和成長性股票都在下跌。\n投機股、SPACs、小盤股、中盤股、記憶股和成長股自2月以來都處於下跌的漩渦中。\n自2月以來，超過45%以上。那麼，我們處於什麼泡沫中，當它只是...","locale":"zh-Hant"}]}}},"pageContext":{"basePath":"/","pageType":"detail","id":"TweetPost-1429962955916038148","previousId":"TweetPost-1429898657424347143","nextId":"RedditPost-87fa8a15-e0c9-5a0f-ae6d-0676dd8bb733","maxWidth":1024,"siteMetadata":null,"locale":"zh","hrefLang":"zh-Hans","originalPath":"/tweet/1429962955916038148","dateFormat":"YYYY-MM-DD"}},"staticQueryHashes":["1239077767","2744905544","3280999885"]}